₹10.85
▼ -0.05 -0.46%
18 Jul 2026
NSE Listed
ESM 1Nectar Lifesciences Ltd. (NECLIFE)
Volume: 1,00,885Avg Vol 1W: 1,04,618.4Avg Vol 1M: 1,10,775.452W Range:₹9.3₹22.4
Key Ratios
Checked 3h agoMarket Cap₹210 Cr
Current Price₹10.85
Previous Close₹10.9
High / Low (52w)₹22.4 / ₹9.3
Volume1,00,885
Avg Vol (1W)1,04,618.4
Avg Vol (1M)1,10,775.4
Stock P/E—
Book Value₹29.97
Dividend Yield0%
ROE-9.85%
ROA-47.12%
Revenue (TTM)₹1,675 Cr
Revenue Growth-0.8%
Profit Margin-4,762.44%
Total Debt₹60 Cr
Shares Outstanding19 Cr
Face Value₹1
EPS (TTM)₹0
P/B0.36
Debt / Equity0.6
50 DMA₹11.7
200 DMA₹13.79
Day change-0.46%
SurveillanceESM 1 (as of 2026-07-16)
Price Chart
₹10.85▼ 39.18% · 1Y
2025-07-182026-07-17
20-day avg volume: 1.1L shares
Pros
- Company is almost debt-free.
- Stock trades below its book value.
Cons
- Revenue fell 33% YoY.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹359 Cr | ₹6 Cr | ₹0 Cr | ₹0 Cr | ₹5 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr |
| EBITDA | ₹25 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹-1 Cr | ₹-51 Cr |
| Net Profit | ₹3 Cr | ₹6 Cr | ₹8 Cr | ₹-130 Cr | ₹-63 Cr | ₹-176 Cr | ₹14 Cr | ₹-68 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,882 Cr | ₹2,789 Cr | ₹2,371 Cr | ₹1,547 Cr | ₹1,680 Cr | ₹1,567 Cr | ₹1,699 Cr | ₹1,675 Cr |
| EBITDA | ₹178 Cr | ₹207 Cr | ₹163 Cr | ₹53 Cr | ₹113 Cr | ₹37 Cr | ₹105 Cr | ₹-87 Cr |
| Net Profit | ₹52 Cr | ₹48 Cr | ₹32 Cr | ₹-73 Cr | ₹25 Cr | ₹-24 Cr | ₹5 Cr | ₹-114 Cr |
| EPS | 2.33 | 2.12 | 1.42 | -3.27 | 1.12 | -1.08 | 0.22 | -5.07 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹2,724 Cr | ₹2,705 Cr | ₹2,633 Cr | ₹2,471 Cr | ₹2,391 Cr | ₹2,189 Cr | ₹2,191 Cr | ₹2,047 Cr |
| Total Liabilities | ₹1,665 Cr | ₹1,600 Cr | ₹1,497 Cr | ₹1,409 Cr | ₹1,303 Cr | ₹1,125 Cr | ₹1,122 Cr | ₹1,091 Cr |
| Equity | ₹1,059 Cr | ₹1,105 Cr | ₹1,136 Cr | ₹1,062 Cr | ₹1,088 Cr | ₹1,065 Cr | ₹1,069 Cr | ₹956 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹78 Cr | ₹253 Cr | ₹294 Cr | ₹25 Cr | ₹95 Cr | ₹134 Cr | ₹225 Cr | ₹169 Cr |
| Investing | ₹-29 Cr | ₹-26 Cr | ₹-33 Cr | ₹-29 Cr | ₹17 Cr | ₹52 Cr | ₹-17 Cr | ₹-42 Cr |
| Financing | ₹-40 Cr | ₹-201 Cr | ₹-252 Cr | ₹11 Cr | ₹-119 Cr | ₹-186 Cr | ₹-205 Cr | ₹-128 Cr |
| Free Cash Flow | ₹78 Cr | ₹253 Cr | ₹294 Cr | ₹25 Cr | ₹95 Cr | ₹134 Cr | ₹225 Cr | ₹169 Cr |
Shareholding
Promoter 51.84% Institutions 4.24% Public 43.91%
Efficiency & Working Capital
ROCE-8.7%
Interest Coverage-1.2
Dividend Payout—
Debtor Days66 d
Inventory Days132 d
Payable Days84 d
Cash Conversion Cycle114 d
Working Capital Days198 d
Shareholding Details
As of 2026-06-30
Promoter51.8%
FII0.5%
DII3.7%
Institutions4.2%
Public43.9%
Promoter Pledge0%
No. of Shareholders73,834
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Jan 2026 | Jan 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 55.8% | 55.8% | 55.8% | 44.5% | 44.5% | 44.5% | 44.9% | 44.9% | 51.8% | 51.8% | 51.8% | 51.8% |
| FIIs | 17% | 16.6% | 3.2% | 0.7% | 1.6% | 0.8% | 0.6% | 0.5% | 0.6% | 0.6% | 0.6% | 0.5% |
| DIIs | 0% | 0% | 0% | 0% | 0.2% | 0.2% | 0.1% | 5.8% | 3.5% | 3.5% | 4% | 3.7% |
| Public | 27.2% | 27.6% | 41% | 54.7% | 53.7% | 54.5% | 54.4% | 48.7% | 44% | 44% | 43.5% | 43.9% |
| Promoter Pledge | 100% | 100% | 100% | 99.6% | 99.6% | 99.6% | 98.8% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 59,946 | 58,230 | 66,741 | 69,482 | 69,241 | 71,977 | 76,470 | 78,124 | 76,648 | 76,648 | 74,834 | 73,834 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Sanjiv Goyal | Shareholding of Promoter and Promoter Group | 24.6% | 4.78 Cr |
| Sanjiv (huf) - Karta Sanjiv Goyal | Shareholding of Promoter and Promoter Group | 22.5% | 4.36 Cr |
| Raman Goyal | Shareholding of Promoter and Promoter Group | 4.8% | 92,38,448 |
| Rajasthan Global Securities Private Limited | Public Shareholding | 3.7% | 72,47,763 |
| Nectar Organics Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Orient Alloys Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Sanjiv (huf) - Karta Sanjiv Goyal | 0 | 0% | 2026-06-30 |
| Sanjiv Goyal | 0 | 0% | 2026-06-30 |
| Raman Goyal | 0 | 0% | 2026-06-30 |
| Nectar Organics Private Limited | 0 | 0% | 2026-06-30 |
| Orient Alloys Private Limited | 0 | 0% | 2026-06-30 |
| Rajasthan Global Securities Private Limited | 0 | 0% | 2026-06-30 |
| Sanjiv (huf) - Karta Sanjiv Goyal | 0 | 0% | 2026-03-31 |
| Sanjiv Goyal | 0 | 0% | 2026-03-31 |
| Raman Goyal | 0 | 0% | 2026-03-31 |
| Nectar Organics Private Limited | 0 | 0% | 2026-03-31 |
| Orient Alloys Private Limited | 0 | 0% | 2026-03-31 |
| Rajasthan Global Securities Private Limited | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Sanjiv Goyal | Chairman & Managing Director | 2025 |
| Rupinder Tewari | Independent Non Exe. Director | 2025 |
| Kuldip Kumar Bhasin | Independent Non Exe. Director | 2025 |
| Indu Pal Kaur | Independent Non Exe. Director | 2025 |
| Surulichamy Senthilkumar | Executive Director | 2025 |
| Sanjaymohan Singh Rawat | Company Sec. & Compli. Officer | 2025 |
| Sushil Kapoor | WTD & Director (Finance) | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceuticals Products | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹1,172 Cr | 61.4% |
| Outside India | ₹737 Cr | 38.6% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹1 | 35 | 22 | 22 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| buyback | 2026-01-06 | ₹27 max | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 6 | 0 | 6 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 1 | 0 | 1 |
Insider / Designated-Person Trades
6 recent disclosure(s)
Raman GoyalAcquisition · 80,00,000
Sanjiv GoyalDisposal · 80,00,000
SBICAP Trustee Company LimitedRevoke · 9,94,68,000
SanjivHUFRevoke · 4,36,22,400
Sanjiv GoyalRevoke · 5,58,45,600
RAMAN GOYALAcquisition · 4,00,000
Substantial Acquisitions (SAST)
12 disclosure(s)
Buy Back20/01/2026 · —
Market12/12/2025 · 3,62,422
Release Of Pledge30/10/2025 · —
Market10/12/2024 · 35,43,356
Market10/12/2024 · 3,66,77,506
Market14/11/2024 · 23,87,012
Company Information
🌐 www.neclife.com ↗
📍 Village Saidpura, Tehsil Derabassi S A S Nagar, Mohali, Punjab, 140507
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search